Trade PSTV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
PLUS THERAPEUTICS Inc (PSTV) is trading at US$3.87, up 0.00% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$26.64M. Over the past 52 weeks, PSTV has traded between US$2.90 and US$23.43. On Syfe you can trade PSTV with $0 commission and add it to your watchlist.
| Previous close | US$3.87 |
|---|---|
| Market cap | US$26.64M |
| 52-week range | US$2.90 – US$23.43 |
| Volume | 96.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
PLUS THERAPEUTICS Inc
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Year: 2000
Plus Therapeutics, Genomic Testing Cooperative to Integrate NGS Technology Into CNSide CSF Assay Platform
Jul 16, 12:04 PM · MT Newswires
Plus Therapeutics Unit Signs Coverage Agreement With Elevance Health for CNSide Assay
Jun 25, 12:17 PM · MT Newswires
Plus Therapeutics Q1 Loss Narrows, Revenue Declines
May 15, 8:17 PM · MT Newswires
PLUS THERAPEUTICS Inc (PSTV) stock is trading at US$3.87, 0.00% from the previous close of US$3.87.
The market cap for PLUS THERAPEUTICS Inc (PSTV) stock is approximately US$26.64M.
The 52-week high for PLUS THERAPEUTICS Inc (PSTV) stock is US$23.43.
The 52-week low for PLUS THERAPEUTICS Inc (PSTV) stock is US$2.90.
PLUS THERAPEUTICS Inc (PSTV) does not currently pay a dividend.
Stay on top of PSTV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
